BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,509,820 | -0.7% | 2,265,761 | +19.9% | 0.05% | +4.2% |
| Q2 2023 | $86,111,088 | +95.9% | 1,890,059 | +74.4% | 0.05% | +92.0% |
| Q1 2023 | $43,964,850 | -18.8% | 1,083,946 | +2.1% | 0.02% | -26.5% |
| Q4 2022 | $54,116,174 | -5.7% | 1,061,726 | -0.4% | 0.03% | -15.0% |
| Q3 2022 | $57,408,674 | -15.3% | 1,065,887 | +1.0% | 0.04% | -14.9% |
| Q2 2022 | $67,812,043 | -18.1% | 1,055,769 | -1.1% | 0.05% | -13.0% |
| Q1 2022 | $82,790,233 | -13.6% | 1,067,710 | -4.3% | 0.05% | -8.5% |
| Q4 2021 | $95,790,000 | -18.6% | 1,115,914 | -23.7% | 0.06% | -38.5% |
| Q3 2021 | $117,633,000 | -27.5% | 1,462,545 | -27.4% | 0.10% | -27.3% |
| Q2 2021 | $162,225,000 | -1.5% | 2,015,210 | +3.2% | 0.13% | -7.7% |
| Q1 2021 | $164,697,000 | -8.4% | 1,952,776 | -12.8% | 0.14% | -13.9% |
| Q4 2020 | $179,746,000 | +5.8% | 2,240,123 | +6.1% | 0.17% | -5.1% |
| Q3 2020 | $169,840,000 | +2.4% | 2,111,906 | +7.3% | 0.18% | +12.2% |
| Q2 2020 | $165,849,000 | +141.6% | 1,969,003 | +132.9% | 0.16% | +105.3% |
| Q1 2020 | $68,655,000 | -20.9% | 845,610 | -18.5% | 0.08% | -16.5% |
| Q4 2019 | $86,748,000 | +72.4% | 1,037,413 | +77.2% | 0.09% | +62.5% |
| Q3 2019 | $50,316,000 | +28.6% | 585,556 | +22.5% | 0.06% | +21.7% |
| Q2 2019 | $39,138,000 | -48.1% | 477,876 | -48.5% | 0.05% | -43.9% |
| Q1 2019 | $75,379,000 | -9.3% | 927,049 | -26.6% | 0.08% | -21.9% |
| Q4 2018 | $83,135,000 | +12.2% | 1,263,066 | +31.5% | 0.10% | +34.6% |
| Q3 2018 | $74,070,000 | -27.2% | 960,821 | -30.3% | 0.08% | -29.7% |
| Q2 2018 | $101,729,000 | +25.9% | 1,377,701 | +10.9% | 0.11% | +24.7% |
| Q1 2018 | $80,791,000 | +59.2% | 1,242,177 | +58.2% | 0.09% | +61.8% |
| Q4 2017 | $50,741,000 | +47.7% | 784,983 | +43.3% | 0.06% | +34.1% |
| Q3 2017 | $34,365,000 | -14.5% | 547,654 | -17.6% | 0.04% | -16.3% |
| Q2 2017 | $40,213,000 | -20.0% | 664,253 | -31.5% | 0.05% | -23.4% |
| Q1 2017 | $50,280,000 | +32.0% | 969,540 | +12.8% | 0.06% | +18.5% |
| Q4 2016 | $38,100,000 | -6.8% | 859,292 | +0.1% | 0.05% | -11.5% |
| Q3 2016 | $40,864,000 | -55.5% | 858,455 | -57.7% | 0.06% | -56.7% |
| Q2 2016 | $91,737,000 | -37.7% | 2,028,682 | -43.2% | 0.14% | +11.0% |
| Q1 2016 | $147,306,000 | +25.4% | 3,570,185 | +16.0% | 0.13% | +13.4% |
| Q4 2015 | $117,435,000 | +28.3% | 3,078,225 | +10.5% | 0.11% | +15.5% |
| Q3 2015 | $91,535,000 | -7.2% | 2,786,446 | +7.4% | 0.10% | -17.8% |
| Q2 2015 | $98,588,000 | +20.3% | 2,595,104 | +17.9% | 0.12% | +13.5% |
| Q1 2015 | $81,942,000 | -42.1% | 2,201,982 | +14.1% | 0.10% | -49.3% |
| Q4 2014 | $141,430,000 | +35.8% | 1,929,726 | +32.9% | 0.20% | +33.1% |
| Q3 2014 | $104,179,000 | -7.0% | 1,451,577 | -6.3% | 0.15% | -9.4% |
| Q2 2014 | $112,033,000 | +25.9% | 1,549,565 | +28.2% | 0.17% | +19.7% |
| Q1 2014 | $88,964,000 | +0.2% | 1,209,071 | -5.3% | 0.14% | +2.9% |
| Q4 2013 | $88,784,000 | +17.3% | 1,276,554 | +10.8% | 0.14% | +9.5% |
| Q3 2013 | $75,667,000 | -32.7% | 1,151,891 | -29.0% | 0.13% | -40.6% |
| Q2 2013 | $112,383,000 | – | 1,622,396 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |